Navin Fluorine’s June quarter results were broadly in line with our expectations. Watch the video to find out what investors could do with the stock now.
Navin Fluorine, which is among the select few firms in emerging markets dealing with complex fluorination abilities, is seeing strong interest from multinational innovator companies in the life science and crop science space
In medium term, Navin Fluorine's growth should be driven by higher margin businesses of CRAMS and specialty business segments
Net Sales are expected to increase by 6.5 percent Y-o-Y (up 9.7 percent Q-o-Q) to Rs. 268 crore, according to HDFC Securities.
The company will continue to accord utmost importance to the health and safety of its workforce, the company has told exchanges.
Sakshi Batra does a 3-Point Analysis on the new deal of Navin Fluorine and how it will help the company.
Balrampur Chini is approaching the neckline of an Ascending Triangle pattern placed at Rs 170-171, and a breakout from the neckline on healthy volumes will lead to a resumption of the bull trend.
Overall, the company remains a beneficiary of strong barriers to entry in the fluoro-chemical value chain and going forward, it should gain from the formidable expertise in delivering complex chemical intermediates for the pharmaceuticals industry